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Any book that makes it to a 5th edition over a period of 18
years must be doing something right. During this time, the
importance of tuberculosis as a major worldwide killer has
become increasingly recognized even if the international
battle to diagnose and treat more patients has a fair way
to go. In 2006, more research on tuberculosis was undertaken
and there are signs of the first new drugs in the field for many
years. At the same time, concerns have arisen over increasing
drug resistance most recently in the form of Extreme drug-
resistant TB (XDR-TB). The rightful dominant place of Myco-
bacterium tuberculosis has tended to put other related
organisms in the shade despite their clinical importance.
For all these reasons, I was looking forward to taking a closer
look at David Schlossberg’s latest volume.
The book is divided into three main sections. The first is
entitled ‘General considerations’,which includesareas suchas
epidemiology, laboratorydiagnosis, issuesaround latent tuber-
culosis and vaccines. Section two is on ‘Clinical syndromes’.
The main organs affected by tuberculosis are considered
sequentially (although not in order of clinical importance)
before consideration of some of the indirect effects of infec-
tions and the interactions between tuberculosis and HIV. The
third section of the book focuses on the nontuberculous myco-
bacterial syndromes. Individualchaptersarewrittenbyaseries
of eminent experts and as is often the case, this is both a
strength and a weakness. Some people are rather too keen on
their own perspective. For example, in the excellent chapter
on tuberculosis as seen from a World Health Organization
(WHO) perspective, there is no real consideration of some of
the limits and criticisms of thedirectly observed therapy (DOT)
strategy. Overall, a great deal of information is packed into a
relatively slim volume. Although reasonably up to date, the
immunology chapter, for example, has its most recent refer-
ences in 2003 and there has been progress since then.
Tuberculosis is a disease with worldwide distribution. The
major problems concerning diagnosis and management of
tuberculosis are found in resource-poor areas. Early on in the
book, it is noted that migrants to the USA are a major source
of disease but the international nature of the problem is not
well reflected. With the exception of the authors of the
chapters on surgery, the WHO perspective, upper respiratory1201-9712/$32.00 # 2007 International Society for Infectious Diseases.tuberculosis and on Mycobacterium kansasii, all the authors
are from the USA. There is a strong North American slant to
everything that is said and this will be a downside to many
who may be interested in this compact volume.
The section on nontuberculous mycobacteria focuses
heavily on the Mycobacterium avium complex. There are
good chapters on Mycobacterium kansasii, Mycobacterium
marinum and Mycobacterium scrofulaceum. However, there
is no detailed consideration of Mycobacterium ulcerans, an
organism that is fascinating both for the pathology it causes
and its very unusual toxin-based mechanism of disease, or of
Mycobacterium chelonae or Mycobacterium abscessus, rele-
vant in the context of implants and dialysis.
At the end of the day I am pleased to have this book on my
shelf and I amaware of its limitations. I would recommend it to
any doctor involved in the field of infectious diseases, respira-
torymedicine or other areas that bring them into close contact
with mycobacteria. There is rather too much information in
the book for a medical student and its limitations will restrict
its interest to those at the forefront of TB management in
resource-poor countries. All in all, although it is always pos-
sible to find criticisms in a volume of this size, the 5th edition
deserves to be the forerunner of the 6th edition!
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The origin and epicenter of the SARS (severe acute respira-
tory syndrome) epidemic was China and the Western Pacific
Region, where more than 95% of the cases occurred. This
book is a chronicle of the outbreak of severe pneumonia,
which spread rapidly across the globe to 12 countries as a
result of international travel by air.
The chronology of the SARS outbreak (Chapter 1) is truly
remarkable and will serve as an important historical docu-Published by Elsevier Ltd. All rights reserved.
